HNSBF
Hansa Biopharma AB (publ)
Set alert
3.29 USD 0.00 0.00%
2.93 Day range 2.93
2.90 52-week range 4.58
- YTD
- +13.02%
- 1 year
- -28.19%
- Open
- 2.93
- Prev close
- 3.29
- Mkt cap
- 328.02M
- Vol
- 150
- Avg vol
- 93
- EPS
- -0.84
- P/E
- 0.00
More statistics
- Low
- 2.93
- High
- 2.93
News
- Hansa Biopharma announces positive Idefirix PAES results presented in the High-Impact Clinical Trials session at ASN Kidney Week
- Hansa Biopharma AB (publ) (OTCMKTS:HNSBF) Sees Large Increase in Short Interest
- Hansa Biopharma Partners with Cradle to Advance AI-Driven Protein Design and Engineering
- Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
- Hansa Biopharma AB (publ) (HNSBF) Q2 2026 Earnings Call Transcript
- Hansa Biopharma participating in Wedbush PacGrow Renal Summit
- Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA
- Hansa Biopharma AB (publ) (HNSBF) Analyst/Investor Day Transcript
- Hansa Biopharma AB (publ) (HNSBF) Discusses Top Line Results from PAES Study on Imlifidase in Highly Sensitized Kidney Transplant Patients Transcript
- Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation
Your note
Sign in to keep a note on HNSBF — it syncs with the Stock Master app.